Cold medicine can help reduce the risk of miscarriage in pregnancy, researchers say, even though it is not yet available on the Indian market.

The research was published in the Indian Journal of Obstetrics and Gynaecology.

It was done in the absence of cold medicines for both the gestational age and the post-natal age.

Dr K.S. Anand, who led the research, said the study found that cold medicines during the pre-natal and post-pregnancy periods could reduce the incidence of miscarriage by 50 per cent, while cold medicines delivered during pregnancy and delivered during the postnatal period were also effective.

The study, which was funded by the National Institutes of Health (NIH), also found that women in their second trimester could benefit from cold medicine.

“The women in the study who received the cold medicine at pre-pregnant and postnatal time had a statistically significant reduction in the miscarriage rate,” Dr Anand said.

Dr Anad added that the findings were the first to find that women who received cold medicine during pregnancy were more likely to be healthy in post-partum and have a normal weight.

Cold medicine for pregnancy was also recommended for mothers of infants, as well as for women who are obese.

A spokesperson for the Indian Institutes of Technology said in a statement that the results of the study were preliminary and preliminary findings can only help to establish the effectiveness of this cold medicine for postpartum women.

“There are many other cold medicines available in India and there are also many cold medicines that have been available in the market for a long time,” the spokesperson said.

“But we are keen to see the effect of this on the outcomes of postpartums women.”

Dr Anasul Anand of the Indian Institute of Medical Sciences, Bengaluru, said that there were still many questions that needed to be answered before the cold medicines could be made available in Indian markets.

“We need to know whether the women were taking this medicine at a low dose, and also if the dosage is effective for the pre and postpartumer’s use,” Dr. Anasula said.

While Dr Anisula said that cold medicine is available in some Indian pharmacies, they could be very expensive.

“A high-dose cold medicine might cost between Rs. 4,000 to Rs. 10,000, so the price is high for most Indian pharmacies,” she said.

Anad said that the study looked at women who were pregnant at a very early stage, so it would be difficult to predict if cold medicines would be effective for women at any stage of their pregnancies.

However, the researchers also noted that the women in this study were very healthy.

“For the postpartUM women, the study showed that cold remedies delivered during pre-partuma pregnancy were significantly more effective than cold medicines delivering during the later part of pregnancy,” Dr K, Anand added.

A study conducted by researchers at the Indian Centre for Tropical Medicine Research (ICTMR) found that the use of cold medicine could prevent complications in pregnant women who suffer from respiratory illnesses such as COPD, a disease caused by breathing in CO2.

The results of this study have been published in Indian Journal for Tropical Health and Hygiene.

In addition to being beneficial for pregnant women, cold medicines also provide protection against some diseases.

For instance, in an Australian study, researchers found that mothers who took cold medicines between pregnancy and the birth of their babies were three times more likely than those who did not to be diagnosed with respiratory infections during pregnancy.

“If a pregnant woman has COPD or other respiratory infections, the cold medication can help to prevent the onset of those infections, which is often associated with a prolonged labour,” Dr David Bock, a consultant in infectious diseases at the Australian National University’s Department of Epidemiology and Biostatistics, said in an interview with The Australian.

In the study, published in BMC Pregnancy and Childbirth, researchers recruited more than 8,000 women who had had a pregnancy that was between 6 and 10 weeks and who had taken at least four cold medicines.

Participants who were diagnosed with COPD during pregnancy also had a higher incidence of complications in the birth.

For the study published in Pediatrics, researchers tracked 1,200 women who gave birth between March and September 2017, and tracked their mothers for more than 12 months after birth.

Of those who took at least three cold medicines, women who took the cold pills during the first six months of pregnancy were twice as likely to have respiratory infections as women who did no medicine at all.

They also were more than three times as likely than women who got no medicine to be hospitalized during labour.

“When pregnant women are on the pill, they are protected from complications and have the best chance of surviving and returning to labour,” Bock said.

According to the study: “The protective effect of the cold-medicines against respiratory